Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Esbjerg Hospital - University Hospital of Southern Denmark
1,200 participants
Aug 15, 2018
INTERVENTIONAL
Conditions
Summary
Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
Eligibility
Inclusion Criteria6
- Age > 18 years
- BMI >35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
- Able to give written informed consent.
- Age > 18 years
- BMI >35 kg/m2 with no wish to undergo bariatric surgery.
- Able to give written informed consent.
Exclusion Criteria3
- Active viral hepatitis
- Not willing or able to consent
- Contraindications to liver biopsy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Roux en y gastric bypass or gastric sleeve operation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03535142